Strumento inattivo

Altre lingue Jounce Therapeutics, Inc.

Azioni

JNCE

US4811161011

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Graphite Bio, Inc. Announces Executive Changes	23/08/23
JOUNCE THERAPEUTICS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form 8-K)	04/05/23
Jounce Therapeutics, Inc. Announces Board Changes	04/05/23
Jounce Therapeutics, Inc.(NasdaqGS:JNCE) dropped from NASDAQ Composite Index	04/05/23
Jounce Therapeutics, Inc.(NasdaqGS:JNCE) dropped from S&P Global BMI Index	04/05/23
Jounce Therapeutics, Inc.(NasdaqGS:JNCE) dropped from S&P TMI Index	04/05/23
Jounce Therapeutics Announces Closing of Tender Offer	04/05/23
Concentra Biosciences, LLC completed the acquisition of Jounce Therapeutics, Inc. from Tang Capital Management, LLC and others.	03/05/23
Redx confirms Jounce deal lapses, Tirupati seals deal	03/04/23
Redx Pharma Shares Fall 5% as Merger With Jounce Therapeutics Fails	03/04/23
Termination of Proposed Business Combination of Jounce Therapeutics, Inc. and Redx Pharma plc	03/04/23
JOUNCE THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)	30/03/23
Jounce Therapeutics, Inc. Expects Resignation of Elizabeth Trehu as Chief Medical Officer	30/03/23
Sector Update: Health Care Stocks Rise in Late Trading	27/03/23
Sector Update: Health Care Stocks Higher in Afternoon Trading	27/03/23
European Stock Markets Close Higher Monday as First Citizens BancShares' Planned Acquisition of Silicon Valley Bank Assets, Deposits Eases Banking Crisis Fears	27/03/23
Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs	27/03/23
Redx Pharma Says Jounce Therapeutics Terminated Merger Deal; Shares Plunge 19%	27/03/23
Jounce Therapeutics Agrees to be Acquired by Concentra Biosciences	27/03/23
Redx Pharma's bid to buy Jounce snubbed by Concentra's higher offer	27/03/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Jounce Therapeutics, Inc.

Azioni

JNCE

US4811161011

Altre lingue

Filtri